<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ADHD Medications: A Quick Guide</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        body {
            font-family: 'times new roman', sans-serif; /* User's existing font preference */
            /* background-color: #ffffff; /* Changed from bg-slate-100 */
        }
        /* Custom styles for better visual appeal if needed */
        .icon-warning { color: #e53e3e; /* red-600 */ }
        .section-title-stimulant { border-bottom-color: #0ea5e9; /* sky-500 */ }
        .section-title-non-stimulant { border-bottom-color: #14b8a6; /* teal-500 */ }
        .card-stimulant { background-color: #f0f9ff; /* sky-50 */ border: 1px solid #e0f2fe; /* sky-100 */ }
        .card-non-stimulant { background-color: #f0fdfa; /* teal-50 */ border: 1px solid #ccfbf1; /* teal-100 */ }
        .highlight-risk { color: #dc2626; font-weight: bold; } /* red-600 */

        /* Simple SVG Icons (Heroicons MIT License - https://heroicons.com) */
        .icon-svg {
            width: 1.25rem; /* Tailwind w-5 */
            height: 1.25rem; /* Tailwind h-5 */
            display: inline-block;
            vertical-align: middle;
            margin-right: 0.25rem; /* Tailwind mr-1 */
        }
    </style>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
</head>
<body class="bg-white p-4 md:p-8"> <div class="max-w-5xl mx-auto">
        <header class="text-center mb-10">
            <h1 class="text-3xl md:text-4xl font-bold text-slate-800">ADHD Medications: A Quick Guide</h1>
            <p class="text-slate-600 mt-2">Key information on stimulant and non-stimulant treatments.</p>
        </header>

        <section class="mb-12">
            <h2 class="text-2xl font-semibold text-sky-700 border-b-2 section-title-stimulant pb-2 mb-6 flex items-center">
                <svg class="icon-svg mr-2 text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                    <path stroke-linecap="round" stroke-linejoin="round" d="M3.75 13.5l10.5-11.25L12 10.5h8.25L9.75 21.75 12 13.5H3.75z" />
                </svg>
                A. STIMULANT MEDICATIONS
            </h2>
            <div class="bg-white p-4 rounded-lg shadow-md mb-6 border border-slate-200"> <p class="text-sm text-slate-700 mb-2"><strong>Overview:</strong> Most common for ADHD; work by increasing dopamine and/or norepinephrine.</p>
                <p class="text-sm text-slate-700 font-medium mb-1">General Considerations:</p>
                <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                    <li>Mood monitoring is always important; therapeutic use generally <strong class="text-green-600">lowers</strong> risk of subsequent substance use disorders; not typically associated with classical physical dependence in therapeutic use.</li>
                </ul>
            </div>

            <div class="grid md:grid-cols-2 gap-6">
                <div class="card-stimulant p-5 rounded-lg shadow-lg hover:shadow-xl transition-shadow duration-300">
                    <h3 class="text-xl font-semibold text-sky-700 mb-1">1. Methylphenidate-Based</h3>
                    <p class="text-xs text-slate-500 mb-3">(e.g., Ritalin, Concerta, Focalin)</p>

                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M3.75 13.5l10.5-11.25L12 10.5h8.25L9.75 21.75 12 13.5H3.75z" />
                            </svg>
                            How they work (simplified):
                        </h4>
                        <p class="text-sm text-slate-600">Impact norepinephrine & dopamine; primarily help hyperactivity, impulsivity, and support attention/focus.</p>
                    </div>

                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M9 12.75L11.25 15 15 9.75M21 12a9 9 0 11-18 0 9 9 0 0118 0z" />
                            </svg>
                            Reported Profile & Key Differences:
                        </h4>
                        <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                            <li>Effective for many individuals.</li>
                            <li>Often a milder cardiovascular side effect profile for some (vs. amphetamines).</li>
                            <li>Extensive history of use (long-term safety/efficacy data).</li>
                            <li><strong>Mania/Psychosis Risk:</strong> Generally <strong class="text-green-600">NOT</strong> associated with increased risk.
                                <ul class="list-circle list-inside pl-4 text-xs">
                                    <li>Bipolar Disorder: Not linked to increased mania risk on initiation; may even reduce risk with mood stabilizers. *Careful monitoring essential.*</li>
                                </ul>
                            </li>
                            <li><strong>Growth Effects:</strong> Potential modest effects on child growth; regular monitoring needed.</li>
                        </ul>
                    </div>

                    <div>
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M10.5 6h9.75M10.5 6a1.5 1.5 0 11-3 0m3 0a1.5 1.5 0 10-3 0M3.75 6H7.5m3 12h9.75m-9.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-3.75 0H7.5m9-6h3.75m-3.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-9.75 0h9.75" />
                            </svg>
                            Common Side Effects:
                        </h4>
                        <p class="text-sm text-slate-600">Decreased appetite, difficulty sleeping, headache, stomachache, irritability.</p>
                    </div>
                </div>

                <div class="card-stimulant p-5 rounded-lg shadow-lg hover:shadow-xl transition-shadow duration-300">
                    <h3 class="text-xl font-semibold text-sky-700 mb-1">2. Amphetamine-Based</h3>
                    <p class="text-xs text-slate-500 mb-3">(e.g., Adderall, Vyvanse, Dexedrine)</p>

                     <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M3.75 13.5l10.5-11.25L12 10.5h8.25L9.75 21.75 12 13.5H3.75z" />
                            </svg>
                            How they work (simplified):
                        </h4>
                        <p class="text-sm text-slate-600">Significantly impact dopamine & norepinephrine; strong effect on motivation, focus (especially for non-preferred tasks).</p>
                    </div>

                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                             <svg class="icon-svg text-red-500" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />
                            </svg>
                            Reported Profile & Key Differences:
                        </h4>
                        <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                            <li>Often highly effective across a broad range of ADHD symptoms.</li>
                            <li><span class="highlight-risk">Mania/Psychosis Risk:</span> <strong class="highlight-risk">SIGNIFICANT RISK</strong> of inducing/exacerbating mania in Bipolar Disorder. *CRITICAL to rule out Bipolar Disorder before prescribing.*</li>
                            <li>Can also cause new/worsened psychotic symptoms (rare).</li>
                            <li>May trigger agitation or mania-like symptoms. *Careful monitoring essential.*</li>
                            <li><strong>Growth Effects:</strong> Potential modest effects on child growth; regular monitoring needed.</li>
                        </ul>
                    </div>
                     <div>
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                           <svg class="icon-svg text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M10.5 6h9.75M10.5 6a1.5 1.5 0 11-3 0m3 0a1.5 1.5 0 10-3 0M3.75 6H7.5m3 12h9.75m-9.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-3.75 0H7.5m9-6h3.75m-3.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-9.75 0h9.75" />
                            </svg>
                            Common Side Effects:
                        </h4>
                        <p class="text-sm text-slate-600">Decreased appetite, difficulty sleeping, anxiety, irritability; effects can be more intense for some.</p>
                    </div>
                </div>
            </div>
        </section>

        <section>
            <h2 class="text-2xl font-semibold text-teal-700 border-b-2 section-title-non-stimulant pb-2 mb-6 flex items-center">
                <svg class="icon-svg mr-2 text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                    <path stroke-linecap="round" stroke-linejoin="round" d="M12 6.042A8.967 8.967 0 006 3.75c-1.052 0-2.062.18-3 .512v14.25A8.987 8.987 0 016 18c2.305 0 4.408.867 6 2.292m0-14.25a8.966 8.966 0 016-2.292c1.052 0 2.062.18 3 .512v14.25A8.987 8.987 0 0018 18a8.967 8.967 0 00-6 2.292m0-14.25v14.25" />
                </svg>
                B. NON-STIMULANT MEDICATIONS
            </h2>
            <div class="bg-white p-4 rounded-lg shadow-md mb-6 border border-slate-200"> <p class="text-sm text-slate-700 mb-2"><strong>Overview:</strong> Alternatives if stimulants are not suitable or not preferred; work differently.</p>
                <p class="text-sm text-slate-700 font-medium mb-1">General Considerations:</p>
                <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                     <li>Some types may require gradual dose changes if being discontinued to avoid discontinuation effects or rebound symptoms.</li>
                </ul>
            </div>

            <div class="grid md:grid-cols-2 gap-6">
                <div class="card-non-stimulant p-5 rounded-lg shadow-lg hover:shadow-xl transition-shadow duration-300">
                    <h3 class="text-xl font-semibold text-teal-700 mb-1">1. Atomoxetine (Strattera)</h3>
                    <p class="text-xs text-slate-500 mb-1">FDA-Approved Age: Children (6+), adolescents, and adults.</p>

                    <div class="mb-3 mt-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M8.25 7.5V6.108c0-1.135.845-2.098 1.976-2.192.373-.03.748-.03 1.123 0 1.131.094 1.976 1.057 1.976 2.192V7.5M8.25 7.5h7.5M8.25 7.5V9a.75.75 0 01-.75.75H5.25A.75.75 0 014.5 9V7.5m8.25 0V9A.75.75 0 0012.75 9.75H9.75A.75.75 0 009 9V7.5m4.5 0H12m0 0V6.108c0-1.135-.845-2.098-1.976-2.192a48.424 48.424 0 00-1.123 0C7.734 4.016 6.89 4.979 6.89 6.108V7.5m6.11 0h.01" />
                            </svg>
                            How it works:
                        </h4>
                        <p class="text-sm text-slate-600">Selective Norepinephrine Reuptake Inhibitor (SNRI); primarily targets the norepinephrine system.</p>
                    </div>

                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                             <svg class="icon-svg text-red-500" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />
                            </svg>
                            Reported Profile:
                        </h4>
                        <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                            <li>Effective for many; requires daily use.</li>
                            <li><span class="highlight-risk">FDA Boxed Warning - Suicidal Ideation:</span> Increased risk in children, adolescents, and young adults (up to age 24), particularly during initial treatment or dosage changes. *Close monitoring essential.*</li>
                            <li>Abrupt cessation can lead to discontinuation symptoms.</li>
                        </ul>
                    </div>
                     <div>
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M10.5 6h9.75M10.5 6a1.5 1.5 0 11-3 0m3 0a1.5 1.5 0 10-3 0M3.75 6H7.5m3 12h9.75m-9.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-3.75 0H7.5m9-6h3.75m-3.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-9.75 0h9.75" />
                            </svg>
                            Common Side Effects:
                        </h4>
                        <p class="text-sm text-slate-600">Upset stomach, fatigue, decreased appetite, mood swings, dizziness.</p>
                    </div>
                </div>

                <div class="card-non-stimulant p-5 rounded-lg shadow-lg hover:shadow-xl transition-shadow duration-300">
                    <h3 class="text-xl font-semibold text-teal-700 mb-1">2. Alpha-2 Adrenergic Agonists</h3>
                    <p class="text-xs text-slate-500 mb-1">(e.g., Guanfacine ER/Intuniv, Clonidine ER/Kapvay)</p>
                    <p class="text-xs text-slate-500 mb-3">FDA-Approved Ages: ER forms typically for children/adolescents (6-17); sometimes used off-label in adults.</p>


                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M8.25 7.5V6.108c0-1.135.845-2.098 1.976-2.192.373-.03.748-.03 1.123 0 1.131.094 1.976 1.057 1.976 2.192V7.5M8.25 7.5h7.5M8.25 7.5V9a.75.75 0 01-.75.75H5.25A.75.75 0 014.5 9V7.5m8.25 0V9A.75.75 0 0012.75 9.75H9.75A.75.75 0 009 9V7.5m4.5 0H12m0 0V6.108c0-1.135-.845-2.098-1.976-2.192a48.424 48.424 0 00-1.123 0C7.734 4.016 6.89 4.979 6.89 6.108V7.5m6.11 0h.01" />
                            </svg>
                            How they work:
                        </h4>
                        <p class="text-sm text-slate-600">Directly stimulate specific norepinephrine receptors (alpha-2 adrenergic), particularly in the prefrontal cortex; thought to strengthen PFC regulation.</p>
                    </div>

                    <div class="mb-3">
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                            <svg class="icon-svg text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M9 12.75L11.25 15 15 9.75M21 12a9 9 0 11-18 0 9 9 0 0118 0z" />
                            </svg>
                            Reported Profile:
                        </h4>
                        <ul class="list-disc list-inside text-sm text-slate-600 space-y-1 pl-4">
                            <li>Particularly helpful for impulsivity, hyperactivity, and emotional regulation.</li>
                            <li>Can be used alone or in combination with stimulants.</li>
                            <li>May need to be tapered to avoid rebound effects (e.g., on blood pressure).</li>
                        </ul>
                    </div>
                     <div>
                        <h4 class="text-sm font-medium text-slate-700 mb-1 flex items-center">
                           <svg class="icon-svg text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                                <path stroke-linecap="round" stroke-linejoin="round" d="M10.5 6h9.75M10.5 6a1.5 1.5 0 11-3 0m3 0a1.5 1.5 0 10-3 0M3.75 6H7.5m3 12h9.75m-9.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-3.75 0H7.5m9-6h3.75m-3.75 0a1.5 1.5 0 01-3 0m3 0a1.5 1.5 0 00-3 0m-9.75 0h9.75" />
                            </svg>
                            Common Side Effects:
                        </h4>
                        <p class="text-sm text-slate-600">Drowsiness or sedation (especially initially), dizziness, low blood pressure, constipation, dry mouth.</p>
                    </div>
                </div>
            </div>
        </section>

        <footer class="text-center mt-12 py-6 border-t border-slate-300">
            <p class="text-xs text-slate-500">Disclaimer: This infographic is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.</p>
            <p class="text-xs text-slate-500 mt-1">Information based on provided text summarizing clinical findings and guidelines. Citations in original text (e.g., Wilens et al., 2003; Solmi et al., 2019; Rohde et al., 2023; Poulton et al., 2016; Moran et al., 2019) are not repeated here for brevity but are important context.</p>
        </footer>
    </div>
</body>
</html>
